Vivani
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1350 S Loop Rd, Alameda, California, 945...Phone Number
(415) 506-8462Website
www.vivani.comRevenue
$7.8 MillionStock Symbol
VANIIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Vivani
Vivani Medical, Inc. is a clinical stage company that develops implants that treat chronic diseases with high unmet medical need. Founded in 2010 and headquartered in California, United States.Explore more
Vivani Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vivani your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Vivani launches new products
Congratulate Masked Content for being promoted to Masked Content at Vivani
Earning: See what the market has to say on Vivani recently announced quarterly report
Check if Vivani has recently received funding, and reach out quickly before it becomes old news!
Check out if Vivani is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Vivani, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Vivani has new funding data
Click to see if Vivani had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Vivani as Masked Content
Find 3 more new buyers
Compare Similar Companies to Vivani
Compare insights from companies similar to Vivani, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vivani is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Vivani is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Vivani.
Vivani financials insights
Gather financial insights about Vivani, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Stock Offering
$31.5M
2021
Stock Offering
$57.5M
2024
Other Financing Round
$15M
2025
Share Placement
$8.3M
Other Financing Round
$10M
Vivani Tech Stack
A closer look at the technologies used by Vivani
See more technologies
Most Recent Scoops
Hiring Plans
Vivani has more open roles in Operations than it has had at any time in the past 12 months with an increased focus that include Calibration, and experience with Evaluation Strategy, Refrigeration, Facility Maintenance Management, Manufacturing Operations, Machine Assembly, and Electricity.
Hiring Plans
Open Position
Open Position
Open Position
Open Position
Vivani News & Media
Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026
ALAMEDA, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, announced today that CEO Adam Mendelsohn, Ph.D., will present a company overview and host investor and partner meetings at the Jefferies Global Healthcare Conference taking place June 2-4, 2026 in New York, New York.Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update
Initiation of SLIM-1™ clinical trial, a Phase 1 study of NPM-139, a semaglutide implant under development for chronic weight management, on track for mid-year 2026Vivani Medical price target lowered to $3.50 from $4 at H.C. Wainwright
H.C. Wainwright analyst Yi Chen lowered the firm’s price target on Vivani Medical (VANI) to $3.50 from $4 and keeps a Buy rating on the shares after the company recently reported its 2025 results, citing an increased share count for the firm’s lowered target. The firm believes NPM-139 is uniquely positioned to potentially offer efficacy comparable to Wegovy while requiring only once or twice yearly administration, the analyst tells investors.End of Quarter Sale - 50%Vivani Medical Reports Fourth Quarter and Full Year 2025 Financia - The National Law Review
Successful completion of first-in-human study LIBERATE-1 paired with preclinical proof of concept data for a semaglutide implant advance NPM-139, miniature, ultra lo
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vivani
Sign Up For FreeTo access detailed company insights
Vivani Medical, Inc. is a clinical stage company that develops implants that treat chronic diseases with high unmet medical need. Founded in 2010 and headquartered in California, United States.... Read More
